Valentina Lovato

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Current anti-inflammatory strategies for the treatment of pulmonary disease in cystic fibrosis (CF) are limited; thus, there is continued interest in identifying additional molecular targets for therapeutic intervention. Given the emerging role of sphingolipids (SLs) in various respiratory disorders, including CF, drugs that selectively target the enzymes(More)
  • 1